☰

Mohamed H. Abdel-Rahman, Ph.D. - Publications

Affiliations: 
Ohio State University, Columbus, Columbus, OH 
Area:
pathobiology of brain cancer
Tree Info Grants Similar researchers PubMed Report error

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Abdel-Rahman MH, Sample KM, Pilarski R, Walsh T, Grosel T, Kinnamon D, Boru G, Massengill JB, Schoenfield L, Kelly B, Gordon D, Johansson P, DeBenedictis MJ, Singh A, Casadei S, et al. Whole Exome Sequencing Identifies Candidate Genes Associated with Hereditary Predisposition to Uveal Melanoma. Ophthalmology. PMID 32081490 DOI: 10.1016/J.Ophtha.2019.11.009  0.338
2019 Boru G, Cebulla CM, Sample KM, Massengill JB, Davidorf FH, Abdel-Rahman MH. Heterogeneity in Mitogen-Activated Protein Kinase (MAPK) Pathway Activation in Uveal Melanoma With Somatic GNAQ and GNA11 Mutations. Investigative Ophthalmology & Visual Science. 60: 2474-2480. PMID 31173078 DOI: 10.1167/Iovs.18-26452  0.311
2019 Boru G, Grosel TW, Pilarski R, Stautberg M, Massengill JB, Jeter J, Singh A, Marino MJ, McElroy JP, Davidorf FH, Cebulla CM, Abdel-Rahman MH. Germline large deletion of BAP1 and decreased expression in non-tumor choroid in uveal melanoma patients with high risk for inherited cancer. Genes, Chromosomes & Cancer. PMID 30883995 DOI: 10.1002/Gcc.22752  0.406
2019 Shahriyari L, Abdel-Rahman M, Cebulla C. BAP1 expression is prognostic in breast and uveal melanoma but not colon cancer and is highly positively correlated with RBM15B and USP19. Plos One. 14: e0211507. PMID 30716094 DOI: 10.1371/Journal.Pone.0211507  0.313
2018 Walpole S, Pritchard AL, Cebulla CM, Pilarski R, Stautberg M, Davidorf FH, de la Fouchardière A, Cabaret O, Golmard L, Stoppa-Lyonnet D, Garfield E, Njauw CN, Cheung M, Turunen JA, Repo P, ... ... Abdel-Rahman MH, et al. Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide. Journal of the National Cancer Institute. PMID 30517737 DOI: 10.1093/Jnci/Djy171  0.339
2017 Robertson AG, Shih J, Yau C, Gibb EA, Oba J, Mungall KL, Hess JM, Uzunangelov V, Walter V, Danilova L, Lichtenberg TM, Kucherlapati M, Kimes PK, Tang M, Penson A, ... ... Abdel-Rahman MH, et al. Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell. 32: 204-220.e15. PMID 28810145 DOI: 10.1016/J.Ccell.2017.07.003  0.309
2016 Rai K, Pilarski R, Boru G, Rehman M, Saqr AH, Massengill JB, Singh A, Marino MJ, Davidorf FH, Cebulla CM, Abdel-Rahman M. Germline BAP1 Alterations in Familial Uveal Melanoma. Genes, Chromosomes & Cancer. PMID 27718540 DOI: 10.1002/Gcc.22424  0.362
2016 Abdel-Rahman MH, Rai K, Pilarski R, Davidorf FH, Cebulla CM. Germline BAP1 mutations misreported as somatic based on tumor-only testing. Familial Cancer. PMID 26748926 DOI: 10.1007/S10689-016-9865-9  0.395
2016 Kirchhoff T, Ucisik-Akkaya E, Vogelsang M, Rai K, Pilarski R, Martinez CN, Ferguson R, Kazlow E, Osman I, Davidorf FH, Cebulla CM, Abdel-Rahman M. The identification of novel genetic risk loci in uveal melanoma. Journal of Clinical Oncology. 34: 1543-1543. DOI: 10.1200/Jco.2016.34.15_Suppl.1543  0.333
2015 Rai K, Pilarski R, Cebulla CM, Abdel-Rahman MH. Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases. Clinical Genetics. PMID 26096145 DOI: 10.1111/Cge.12630  0.414
2015 Cebulla CM, Binkley EM, Pilarski R, Massengill JB, Rai K, Liebner DA, Marino MJ, Singh AD, Abdel-Rahman MH. Analysis of BAP1 Germline Gene Mutation in Young Uveal Melanoma Patients. Ophthalmic Genetics. 36: 126-31. PMID 25687217 DOI: 10.3109/13816810.2015.1010734  0.38
2014 Martorano LM, Winkelmann RR, Cebulla CM, Abdel-Rahman MH, Campbell SM. Ocular melanoma and the BAP1 hereditary cancer syndrome: implications for the dermatologist. International Journal of Dermatology. 53: 657-63. PMID 24697775 DOI: 10.1111/Ijd.12386  0.309
2014 Pilarski R, Cebulla CM, Massengill JB, Rai K, Rich T, Strong L, McGillivray B, Asrat MJ, Davidorf FH, Abdel-Rahman MH. Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases. Genes, Chromosomes & Cancer. 53: 177-82. PMID 24243779 DOI: 10.1002/Gcc.22129  0.391
2012 Buzzacco DM, Abdel-Rahman MH, Park S, Davidorf F, Olencki T, Cebulla CM. Long-term survivors with metastatic uveal melanoma. The Open Ophthalmology Journal. 6: 49-53. PMID 22798969 DOI: 10.2174/1874364101206010049  0.314
2012 Abdel-Rahman MH, Cebulla CM, Verma V, Christopher BN, Carson WE, Olencki T, Davidorf FH. Monosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survival. Experimental Eye Research. 100: 26-31. PMID 22569040 DOI: 10.1016/J.Exer.2012.04.010  0.363
2011 Christopher BN, Cebulla CM, Wakely PE, Davidorf FH, Abdel-Rahman MH. Molecular genetic testing of uveal melanoma from routinely processed and stained cytology specimens. Experimental Eye Research. 93: 720-5. PMID 21945171 DOI: 10.1016/J.Exer.2011.09.004  0.341
2011 Abdel-Rahman MH, Pilarski R, Cebulla CM, Massengill JB, Christopher BN, Boru G, Hovland P, Davidorf FH. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. Journal of Medical Genetics. 48: 856-9. PMID 21941004 DOI: 10.1136/Jmedgenet-2011-100156  0.405
2011 Abdel-Rahman MH, Pilarski R, Massengill JB, Christopher BN, Noss R, Davidorf FH. Melanoma candidate genes CDKN2A/p16/INK4A, p14ARF, and CDK4 sequencing in patients with uveal melanoma with relative high-risk for hereditary cancer predisposition. Melanoma Research. 21: 175-9. PMID 21412176 DOI: 10.1097/Cmr.0B013E328343Eca2  0.405
2011 Abdel-Rahman MH, Pilarski R, Massengill JB, Christopher BB, Davidorf FH. Lack of GNAQ germline mutations in uveal melanoma patients with high risk for hereditary cancer predisposition. Familial Cancer. 10: 319-21. PMID 21072599 DOI: 10.1007/S10689-010-9401-2  0.416
2011 Abdel-Rahman MH, Boru G, Cebulla CM, Christopher B, Massengill JB, Frederick DH. Abstract 1127: Lack of MAPK activation in significant number of uveal melanomas with somatic mutation inGNAQandGNA11 Cancer Research. 71: 1127-1127. DOI: 10.1158/1538-7445.Am2011-1127  0.373
2010 Abdel-Rahman MH, Boru G, Massengill J, Salem MM, Davidorf FH. MET oncogene inhibition as a potential target of therapy for uveal melanomas. Investigative Ophthalmology & Visual Science. 51: 3333-9. PMID 20164465 DOI: 10.1167/Iovs.09-4801  0.338
2010 Abdel-Rahman MH, Pilarski R, Ezzat S, Sexton J, Davidorf FH. Cancer family history characterization in an unselected cohort of 121 patients with uveal melanoma. Familial Cancer. 9: 431-8. PMID 20157784 DOI: 10.1007/S10689-010-9328-7  0.363
2010 Abdel-Rahman MH, Pilarski R. Hereditary predisposition rather than environmental factor are likely to explain the familial link between uveal melanoma and other cancers Familial Cancer. 9: 661-662. DOI: 10.1007/S10689-010-9375-0  0.315
2006 Abdel-Rahman MH, Yang Y, Zhou XP, Craig EL, Davidorf FH, Eng C. High frequency of submicroscopic hemizygous deletion is a major mechanism of loss of expression of PTEN in uveal melanoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 288-95. PMID 16344319 DOI: 10.1200/Jco.2005.02.2418  0.364
Show low-probability matches.